79 related articles for article (PubMed ID: 1820926)
1. Biopharmaceutic evaluation of some 4-quinolone derivatives.
Mrhar A; Primozic S; Bogataj M; Kozjek F
Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():473-7. PubMed ID: 1820926
[TBL] [Abstract][Full Text] [Related]
2. Intestinal absorption of a series of 6-fluoquinolone derivatives: a comparative study.
Escribano E; Freixas J; Colom H; Lauroba J; Calpena AC; Domenech J
Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():57-60. PubMed ID: 1820936
[TBL] [Abstract][Full Text] [Related]
3. The pharmacokinetics and tissue penetration of the fluoroquinolones.
Bergeron MG
Clin Invest Med; 1989 Feb; 12(1):20-7. PubMed ID: 2920479
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in situ absorption of etamsylate. Part 2: In vitro and in situ properties.
Yamboliev I; Nikova T; Bogdanova SV
Pharmazie; 1992 Apr; 47(4):282-5. PubMed ID: 1518887
[TBL] [Abstract][Full Text] [Related]
5. Biophysical models as an approach to study passive absorption in drug development: 6-fluoroquinolones.
Merino V; Freixas J; del Val Bermejo M; Garrigues TM; Moreno J; Plá-Delfina JM
J Pharm Sci; 1995 Jun; 84(6):777-82. PubMed ID: 7562422
[TBL] [Abstract][Full Text] [Related]
6. Physicochemical properties of enrofloxacin.
Lizondo M; Pons M; Gallardo M; Estelrich J
J Pharm Biomed Anal; 1997 Aug; 15(12):1845-9. PubMed ID: 9278889
[TBL] [Abstract][Full Text] [Related]
7. [Quinolones: historic review].
Rothlin RP
Medicina (B Aires); 1999; 59 Suppl 1():3-7. PubMed ID: 10436548
[TBL] [Abstract][Full Text] [Related]
8. Structure-absorption relationships of a series of 6-fluoroquinolones.
Escribano E; Calpena AC; Garrigues TM; Freixas J; Domenech J; Moreno J
Antimicrob Agents Chemother; 1997 Sep; 41(9):1996-2000. PubMed ID: 9303400
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of the quinolones in volunteers: a proposed dosing schedule.
Wise R; Griggs D; Andrews JM
Rev Infect Dis; 1988; 10 Suppl 1():S83-9. PubMed ID: 3162327
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of the newer fluoroquinolones.
Brouwers JR
Pharm Weekbl Sci; 1987 Dec; 9 Suppl():S16-22. PubMed ID: 3325926
[TBL] [Abstract][Full Text] [Related]
11. Determination of the partition coefficients, acid dissociation constants, and intrinsic solubility of carbenoxolone.
Blanchard J; Boyle JO; Van Wagenen S
J Pharm Sci; 1988 Jun; 77(6):548-52. PubMed ID: 3171939
[TBL] [Abstract][Full Text] [Related]
12. Quantitative brain microdialysis study on the mechanism of quinolones distribution in the central nervous system.
Ooie T; Terasaki T; Suzuki H; Sugiyama Y
Drug Metab Dispos; 1997 Jul; 25(7):784-9. PubMed ID: 9224772
[TBL] [Abstract][Full Text] [Related]
13. Frequency and expression of mutational resistance to the 4-quinolone antibacterials.
Smith JT
Scand J Infect Dis Suppl; 1986; 49():115-23. PubMed ID: 3547618
[TBL] [Abstract][Full Text] [Related]
14. [The history of the development and changes of quinolone antibacterial agents].
Takahashi H; Hayakawa I; Akimoto T
Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
[TBL] [Abstract][Full Text] [Related]
15. Electrophoretic behaviour of quinolones in capillary electrophoresis. Effect of pH and evaluation of ionization constants.
Barbosa J; Barrón D; Jiménez-Lozano E
J Chromatogr A; 1999 Apr; 839(1-2):183-92. PubMed ID: 10327625
[TBL] [Abstract][Full Text] [Related]
16. Comparative in vitro studies with 4-quinolone antimicrobials.
Felmingham D; O'Hare MD; Robbins MJ; Wall RA; Williams AH; Cremer AW; Ridgway GL; Grüneberg RN
Drugs Exp Clin Res; 1985; 11(5):317-29. PubMed ID: 2941259
[TBL] [Abstract][Full Text] [Related]
17. Structure-tissue distribution relationship based on physiological pharmacokinetics for NY-198, a new antimicrobial agent, and the related pyridonecarboxylic acids.
Okezaki E; Terasaki T; Nakamura M; Nagata O; Kato H; Tsuji A
Drug Metab Dispos; 1988; 16(6):865-74. PubMed ID: 2907467
[TBL] [Abstract][Full Text] [Related]
18. Physicochemical properties of quinolone antibiotics in various environments.
Park HR; Kim TH; Bark KM
Eur J Med Chem; 2002 Jun; 37(6):443-60. PubMed ID: 12204471
[TBL] [Abstract][Full Text] [Related]
19. In vitro study of the interaction between quinolones and polyvalent cations.
Rodríguez Cruz MS; González Alonso I; Sánchez-Navarro A; Sayalero Marinero ML
Pharm Acta Helv; 1999 Feb; 73(5):237-45. PubMed ID: 10085789
[TBL] [Abstract][Full Text] [Related]
20. Comparison between immobilized artificial membrane (IAM) HPLC data and lipophilicity in n-octanol for quinolone antibacterial agents.
Barbato F; Cirocco V; Grumetto L; Immacolata La Rotonda M
Eur J Pharm Sci; 2007 Aug; 31(5):288-97. PubMed ID: 17540545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
